Correction to “Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer”

Key Points

• The aim is to address corrections regarding the apolipoprotein A2 isoform index as a tumor marker for pancreatic cancer.
• Correction to previously published findings on apolipoprotein A2 isoform index.
• Reference DOI provided for clarity.
• Specific results are not provided as this is a correction notice.